Use of endothelial-leukocyte adhesion molecule-1 specific antibodies in the treatment of asthma

摘要

A method for treating asthma in a patient using an agent selected from the group consisting of:PP(a) an antibody capable of binding to ELAM-1;PP(b) a fragment of the antibody (a), the fragment being capable of binding to ELAM-1;P P(c) ELAM-1, being substantially free of natural contaminants; P P(d) a functional derivative of ELAM-1;P P (e) an antibody capable of binding to an ELAM-1 receptor;P P(f) a fragment of the antibody (e), the fragment being capable of binding to an ELAM-1 receptor;PP(g) an ELAM-1 receptor, being substantially free of natural contaminants; and .PP (h) a functional derivative of an ELAM-1 receptor.